Desensitization of an adult patient with Pompe disease and a history of anaphylaxis to alglucosidase alfa

被引：23

作者：

Lipinski, Shawn E. ^{[1
]}

Lipinski, Michael J. ^{[2
]}

Burnette, Autumn ^{[3
]}

Platts-Mills, Thomas A. ^{[3
]}

Wilson, William G. ^{[1
]}

机构：

[1] Univ Virginia Hlth Syst, Dept Pediat, Div Med Genet, Charlottesville, VA 22908 USA

[2] Univ Virginia Hlth Syst, Dept Internal Med, Charlottesville, VA 22908 USA

[3] Univ Virginia Hlth Syst, Asthma & Allerg Dis Ctr, Charlottesville, VA 22908 USA

来源：

MOLECULAR GENETICS AND METABOLISM | 2009年 / 98卷 / 03期

关键词：

Pompe disease; Enzyme replacement therapy; Lysosomal storage disease; Anaphylaxis; Allergy;

D O I：

10.1016/j.ymgme.2009.07.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We report on the successful desensitization of an adult female with Pompe disease who had previously experienced anaphylaxis to intravenous alglucosidase alfa therapy. The starting alglucosidase alfa dose for desensitization was 10 mg/kg with gradual dose escalation and desensitization via serial dilution was completed over five infusions. This methodology serves as a means to desensitize patients with prior anaphylactic response to alglucosidase alfa so that enzyme replacement therapy can be utilized. (C) 2009 Elsevier Inc. All rights reserved.

引用

页码：319 / 321

页数：3

共 50 条

[1] Long-Term Experience with Anaphylaxis and Desensitization to Alglucosidase Alfa in Pompe Disease
Karagol, Hacer Ilbilge Ertoy
Inci, Asli
Terece, Sinem Polat
Kilic, Ayse
Demir, Fevzi
Yapar, Dilek
Koken, Gizem
Okur, Ilyas
Ezgu, Fatih Suheyl
Tumer, Leyla
Bakirtas, Arzu
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (04) : 370 - 375
[2] Desensitisation of the youngest patient with Pompe disease in response to alglucosidase alfa
Karagol, I. H. E.
Bakirtas, A.
Yilmaz, O.
Topal, E.
Kucukcongar, A.
Ezgu, F. S.
Demirsoy, M. S.
Turktas, I.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2014, 42 (04) : 372 - 375
[3] High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa
de Vries, Juna M.
van der Beek, Nadine A. M. E.
Kroos, Marian A.
Ozkan, Lale
van Doorn, Pieter A.
Richards, Susan M.
Sung, Crystal C. C.
Brugma, Jan-Dietert C.
Zandbergen, Adrienne A. M.
van der Ploeg, Ans T.
Reuser, Arnold J. J.
MOLECULAR GENETICS AND METABOLISM, 2010, 101 (04) : 338 - 345
[4] Profile of alglucosidase alfa in the treatment of Pompe disease: safety, efficacy, and patient acceptability
Schneider, Ilka
Zierz, Stephan
RESEARCH AND REPORTS IN ENDOCRINE DISORDERS, 2016, 6 : 1 - 16
[5] Desensitization of two young patients with infantile-onset Pompe disease and severe reactions to alglucosidase alfa
V. Gragnaniello
S. Fecarotta
A. Pecoraro
A. Tarallo
A. Catzola
G. Spadaro
G. Parenti
R. Della Casa
Neurological Sciences, 2019, 40 : 1453 - 1455
[6] Desensitization of two young patients with infantile-onset Pompe disease and severe reactions to alglucosidase alfa
Gragnaniello, V.
Fecarotta, S.
Pecoraro, A.
Tarallo, A.
Catzola, A.
Spadaro, G.
Parenti, G.
Della Casa, R.
NEUROLOGICAL SCIENCES, 2019, 40 (07) : 1453 - 1455
[7] Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis
Hundsberger, Thomas
Roesler, Kai M.
Findling, Oliver
JOURNAL OF NEUROLOGY, 2014, 261 (09) : 1684 - 1690
[8] Alglucosidase alfa therapy for Pompe disease in pregnancy - Case report
Klos, Justyna
Kwasniak-Butowska, Magdalena
Slawek, Jaroslaw
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 375 : 167 - 169
[9] Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis
Thomas Hundsberger
Kai M. Rösler
Oliver Findling
Journal of Neurology, 2014, 261 : 1684 - 1690
[10] Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in adult patients with Pompe disease
Tim A. Kanters
Ans T. van der Ploeg
Michelle E. Kruijshaar
Dimitris Rizopoulos
W. Ken Redekop
Maureen P. M. H. Rutten-van Mӧlken
Leona Hakkaart-van Roijen
Orphanet Journal of Rare Diseases, 12

← 1 2 3 4 5 →